Clinical trial
DHA Supplementation in Patients With STGD3
NCT00420602 · University of Utah, Other · Completed
Key facts
| NCT number | NCT00420602 |
|---|---|
| Title | DHA Supplementation in Patients With STGD3 |
| Official title | Clinical Interventions Against Stargardt Macular Dystrophy: DHA Supplementation in Patients With STGD3 |
| Lead sponsor | University of Utah, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Dominantly Inherited Stargardt's Disease (STGD3) |
| Intervention type | Dietary Supplement |
| Interventions | Over the counter DHA/EPA dietary supplementation |
| Enrollment | 11 |
| Start date | Sep 21, 2007 |
| Primary completion | Dec 27, 2017 |
| Completion | Dec 27, 2017 |
| First posted | Jan 11, 2007 |
| Last update posted | May 9, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: